doi: 10.1161/CIRCULATIONAHA.108.191087.
Epub 2008 Oct 3.
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
- PMID: 18836135
- DOI: 10.1161/CIRCULATIONAHA.108.191087
Item in Clipboard
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Circulation.
.
Erratum in
- Circulation. 2010 Aug 24;122(8):e438
No abstract available
Similar articles
-
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.J Am Coll Cardiol. 2010 Dec 7;56(24):2051-66. doi: 10.1016/j.jacc.2010.09.010. J Am Coll Cardiol. 2010. PMID: 21126648 No abstract available.
-
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17. doi: 10.1016/j.jacc.2008.08.002. J Am Coll Cardiol. 2008. PMID: 19017521 No abstract available.
-
[The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].Recenti Prog Med. 2009 May;100(5):277-8. Recenti Prog Med. 2009. PMID: 19772220 Italian. No abstract available.
-
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.Am J Gastroenterol. 2008 Nov;103(11):2890-907. doi: 10.1111/j.1572-0241.2008.02216.x. Epub 2008 Oct 3. Am J Gastroenterol. 2008. PMID: 18853965 No abstract available.
-
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.Circulation. 2010 Dec 14;122(24):2619-33. doi: 10.1161/CIR.0b013e318202f701. Epub 2010 Nov 8. Circulation. 2010. PMID: 21060077 Review. No abstract available.
Cited by
-
Long-Term Effects of Low-Dose Aspirin on Gastrointestinal Symptoms and Bleeding Complications in Patients with Type 2 Diabetes.Am J Cardiovasc Drugs. 2024 Sep 28. doi: 10.1007/s40256-024-00679-9. Online ahead of print. Am J Cardiovasc Drugs. 2024. PMID: 39340686
-
Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study.BMJ. 2024 Apr 11;385:e076484. doi: 10.1136/bmj-2023-076484. BMJ. 2024. PMID: 38604668 Free PMC article.
-
Assessing peptic ulcer risk with the HAMPROW score in the general Chinese population.Sci Rep. 2024 Feb 23;14(1):4442. doi: 10.1038/s41598-024-55224-0. Sci Rep. 2024. PMID: 38396123 Free PMC article.
-
Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes.Pharmacol Rev. 2024 Feb 13;76(2):228-250. doi: 10.1124/pharmrev.123.000938. Pharmacol Rev. 2024. PMID: 38351070 Review.
-
Appropriateness of proton pump inhibitor therapy in an ambulatory geriatrics clinic: A retrospective cross-sectional analysis.Can Pharm J (Ott). 2023 Oct 11;156(6):331-336. doi: 10.1177/17151635231203214. eCollection 2023 Nov-Dec. Can Pharm J (Ott). 2023. PMID: 38024453 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
